Wantai Biotechnology’s announcement on completing the industrial and commercial change registration and renewing the business license
Securities code: 603392 Securities abbreviation: Wantai Biotechnology Announcement number: 2025-067
Beijing Wantai Biopharmaceutical Co., Ltd.
Announcement on Completion of Industrial and Commercial Change Registration and Renewal of Business License
The company's board of directors and all directors guarantee that the contents of this announcement do not contain any false records, misleading statements or major omissions, and assume legal responsibility for the authenticity, accuracy and completeness of its contents.
Beijing Wantai Biopharmaceutical Co., Ltd. (hereinafter referred to as the "Company") held the 10th meeting of the 6th Board of Directors and the 10th meeting of the 6th Board of Supervisors on October 15, 2025, and held the first extraordinary shareholders' meeting of 2025 on October 31, 2025. The "Proposal on Changing the Use of Partial Repurchase Shares and Cancellation" was reviewed and approved.
Due to the company's repurchase of the 729,970 shares that have been repurchased but not yet used in the special securities account, the purpose was changed from "used for employee stock ownership plans or equity incentives" to "used for cancellation and reduction of registered capital." After this change in the use of part of the repurchased shares, 729,970 shares in the company's special securities account for repurchase were canceled at the China Securities Depository and Clearing Co., Ltd. on December 17, 2025. After the cancellation, the company's total share capital was reduced from 1,265,122,774 shares to 1,264,392,804 shares, and the registered capital was reduced from 1,265,122,774 yuan to 1,264,392,804 yuan. For details, please refer to the "Announcement of Beijing Wantai Biopharmaceutical Co., Ltd. on the Implementation of Cancellation of Repurchased Shares and Changes in Shares" disclosed by the company in the designated information disclosure media on December 17, 2025 (Announcement No.: 2025-064).
Recently, the company completed the industrial and commercial registration change procedures and obtained the "Business License" renewed by the Beijing Changping District Market Supervision Administration. The relevant information is as follows:
Company name: Beijing Wantai Biopharmaceutical Co., Ltd.
Unified social credit code: 91110114600067778R
Type: Other joint stock limited company (listed)
Address: No. 31, Science Park Road, Changping District, Beijing
Legal representative: Qiu Zixin
Registered capital: 1.264392804 yuan
Date of establishment: April 24, 1991
Business scope: Licensed items: pharmaceutical production; pharmaceutical wholesale; pharmaceutical retail; second-class medical device production; third-class medical device production; third-class medical device operation; third-class medical device leasing; pharmaceutical import and export. (Projects that require approval according to law can only be carried out with the approval of relevant departments. Specific business projects are subject to the approval documents or licenses of relevant departments.) General projects: production of Class I medical devices; sales of Class I medical devices; leasing of Class I medical devices; sales of Class II medical devices; leasing of Class II medical devices; technical services, technology development, technical consultation, technology exchange, technology transfer, technology promotion; import and export of goods; import and export of technology; leasing of non-residential real estate; repair of special equipment. (Except for projects that require approval according to law, business activities can be carried out independently with a business license and in accordance with the law) (You are not allowed to engage in business activities that are prohibited or restricted by national and city industrial policies.)
Announcement is hereby made.
Board of Directors of Beijing Wantai Biopharmaceutical Co., Ltd.
December 24, 2025